Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase

NeuroSignals

Volumn 11, Issue 1, 2002, Pages 34-44

  Belcheva, Mariana M ^a   Coscia, Carmine J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium calmodulin; Extracellular signal regulated kinase; G protein; G protein coupled receptor; Growth factor; MAP kinase; Phosphoinositide; Receptor endocytosis; Receptor transactivation; Scaffold

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADAPTOR PROTEIN; BETA ARRESTIN; CALCIUM ION; CALMIDAZOLIUM; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUPHENAZINE; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITIDE; PROTEIN; RAC PROTEIN; RAP PROTEIN; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; WORTMANNIN; GUANINE NUCLEOTIDE BINDING PROTEIN;

BETA CHAIN; CELL LINE; CELL STRAIN; CELL STRAIN 3T3; CELL STRAIN COS7; ENDOCYTOSIS; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; KIDNEY; NERVE CELL; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; PHYSIOLOGY;

ANIMALS; GTP-BINDING PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; RECEPTOR CROSS-TALK;

EID: 0036364093     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057320     Document Type: Review

References (126)

1. Cooper JA, Sefton BM, Hunter T: Diverse mitogenic agents induce the phosphorylation of two related 42,000-dalton proteins on tyrosine in quiescent chick cells. Mol Cell Biol 1984;4:30-37.
2. Kohno M: Diverse mitogenic agents induce rapid phosphorylation of a common set of cellular proteins at tyrosine in quiescent mammalian cells. J Biol Chem 1985;260:1771-1779.
3. Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 2000;103:211-225.
4. Impey S, Obrietan K, Storm DR: Making new connections: Role of ERK MAP kinase signaling in neuronal plasticity. Neuron 1999;23:11-14.
5. Grewal SS, York RD, Stork PJS: Extracellular-signal-regulated kinase signalling in neurons. Curr Opin Neurobiol 1999;9:544-553.
6. Cazaubon S, Chaverot N, Romero IA, Girault JA, Adamson P, Strosberg AD, Couraud PO: Growth factor activity of endothelin-1 in primary astrocytes mediated by adhesion-dependent and -independent pathways. J Neurosci 1997;17:6203-6212.
7. Bohn LM, Belcheva MM, Coscia CJ: Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: Evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade. J Neurochem 2000;74:564-573.
8. Bohn LM, Belcheva MM, Coscia CJ: Mu-opioid agonist inhibition of kappa-opioid receptor-stimulated extracellular signal-regulated kinase phosphorylation is dynamin-dependent in C6 glioma cells. J Neurochem 2000;74:574-581.
9. Koch WJ, Hawes BE, Allen LF, Lefkowitz RJ: Direct evidence that G(i)-coupled receptor stimulation of mitogen-activated protein kinase is mediated by G(beta-gamma) activation of p21(Ras). Proc Natl Acad Sci USA 1994;91:12706-12710.
10. Crespo P, Xu N, Simonds WF, Gutkind JS: Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. Nature 1994;369:418-420.
11. Faure M, Voynoyasenetskaya TA, Bourne HR: cAMP and beta-gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 1994;269:7851-7854.
12. Marinissen MJ, Gutkind JS: G-protein-coupled receptors and signaling networks: Emerging paradigms. Trends Pharmacol Sci 2001;22:368-376.
13. Luttrell LM, Daaka Y, Lefkowitz RJ: Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 1999;11:177-183.
14. Watanabe M, Nakamura M, Sato K, Kano M, Simon MI, Inoue Y: Patterns of expression for the mRNA corresponding to the four isoforms of phospholipase C-beta in mouse brain. Eur J Neurosci 1998;10:2016-2025.
15. Zhang SY, Coso OA, Collins R, Gutkind JS, Simonds WF: A C-terminal mutant of the G protein beta subunit deficient in the activation of phospholipase C-beta. J Biol Chem 1996;271:20208-20212.
16. Belcheva MM, Wong YH, Coscia CJ: Evidence for transduction of mu but not kappa opioid modulation of extracellular signal-regulated kinase activity by G(z) and G(12) proteins. Cell Signal 2000;12:481-489.
17. Belcheva MM, Vogel Z, Ignatova E, Avidorreiss T, Zippel R, Levy R, Young EC, Barg J, Coscia CJ: Opioid modulation of extracellular signal-regulated protein kinase activity is Ras-dependent and involves G (beta-gamma) subunits. J Neurochem 1998;70:635-645.
18. Coscia CJ, Bohn LM, Belcheva MM: Mechanism of kappa and mu opioid modulation of C6 glioma cell proliferation. Soc Neurosci Abstr 1999;25:1035.
19. Inglese J, Koch WJ, Touhara K, Lefkowitz RJ: G-beta-gamma interactions with pH domains and Ras-MAPK signaling pathways. Trends Biochem Sci 1995;20:151-156.
20. Hawes BE, Vanbiesen T, Koch WJ, Luttrell LM, Lefkowitz RJ: Distinct pathways of G(i)-and G(q)-mediated mitogen-activated protein kinase activation. J Biol Chem 1995;270:17148-17153.
21. van Biesen T, Hawes BE, Raymond JR, Luttrell LM, Koch WJ, Lefkowitz RJ: G(o)-protein alpha-subunits activate mitogen-activated protein kinase via a novel protein kinase C-dependent mechanism. J Biol Chem 1996;271:1266-1269.
22. Antonelli V, Bernasconi F, Wong YH, Vallar L: Activation of B-Raf and regulation of the mitogen-activated protein kinase pathway by the G(o) alpha chain. Mol Biol Cell 2000;11:1129-1142.
23. Jordan JD, Carey KD, Stork PJS, Iyengar R: Modulation of Rap activity by direct interaction of G alpha(o) with Rap1 GTPase-activating protein. J Biol Chem 1999;274:21507-21510.
24. Bos JL, Zwartkruis FJT: Rhapsody in G proteins. Nature 1999;400:820-821.
25. Daaka Y, Luttrell LM, Lefkowitz RJ: Switching of the coupling of the beta(2)-adrenergic receptor to different G proteins by protein kinase A. Nature 1997;390:88-91.
26. Zou Y, Komuro I, Yamazaki T, Kudoh S, Uozumi H, Kadowaki T, Yazaki Y: Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy. J Biol Chem 1999;274:9760-9770.
27. Burgering BMT, Pronk GJ, Vanweeren PC, Chardin P, Bos JL: cAMP antagonizes p21(Ras)-directed activation of extracellular signal-regulated kinase-2 and phosphorylation of mSos nucleotide exchange factor. EMBO J 1993;12:4211-4220.
28. Cook SJ, McCormick F: Inhibition by cAMP of Ras-dependent activation of Raf. Science 1993;262:1069-1072.
29. Graves LM, Bornfeldt KE, Raines EW, Potts BC, Macdonald SG, Ross R, Krebs EG: Protein kinase-A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci USA 1993;90:10300-10304.
30. Sevetson BR, Kong XM, Lawrence JC: Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci USA 1993;90:10305-10309.
31. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW: Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′- monophosphate. Science 1993;262:1065-1069.
32. Kurino M, Fukunaga K, Ushio Y, Miyamoto E: Cyclic AMP inhibits activation of mitogen-activated protein kinase and cell proliferation in response to growth factors in cultured rat cortical astrocytes. J Neurochem 1996;67:2246-2255.
33. Schmitt JM, Stork PJS: Beta(2)-adrenergic receptor activates extracellular signal-regulated kinases (ERKs) via the small G protein Rap1 and the serine/threonine kinase b-Raf. J Biol Chem 2000;275:25342-25350.
34. York RD, Molliver DC, Grewal SS, Stenberg PE, McCleskey EW, Stork PJS: Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1. Mol Cell Biol 2000;20:8069-8083.
35. Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJS: cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 1997;89:73-82.
36. Dugan LL, Kim JS, Zhang YJ, Bart RD, Sun YL, Holtzman DM, Gutmann DH: Differential effects of cAMP in neurons and astrocytes. Role of b-Raf. J Biol Chem 1999;274: 25842-25848.
37. Grewal SS, Fass DM, Yao H, Ellig CL, Goodman RH, Stork PJS: Calcium and cAMP signals differentially regulate cAMP-responsive element-binding protein function via a Rap1-extracellular signal-regulated kinase pathway. J Biol Chem 2000;275:34433-34441.
38. Grewal SS, Horgan AM, York RD, Withers GS, Banker GA, Stork PJS: Neuronal calcium activates a Rap1 and B-Raf signaling pathway via the cyclic adenosine monophosphate-dependent protein kinase. J Biol Chem 2000;275:3722-3728.
39. Zanassi P, Paolillo M, Feliciello A, Avvedimento EV, Gallo V, Schinelli S: cAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons. J Biol Chem 2001;276:11487-11495.
40. Martin KC, Michael D, Rose JC, Barad M, Casadio A, Zhu HX, Kandel ER: MAP kinase translocates into the nucleus of he presynaptic cell and is required for long-term facilitation in Aplysia. Neuron 1997;18:899-912.
41. Mochizuki N, Ohba Y, Kiyokawa E, Kurata T, Murakami T, Ozaki T, Kitabatake A, Nagashima K, Matsuda M: Activation of the ERK/MAPK pathway by an isoform of Rap1GAP associated with G alpha(i). Nature 1999;400: 891-894.
42. Kao SC, Jaiswal RK, Kolch W, Landreth GE: Identification of the mechanisms regulating the differential activation of the MAPK cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem 2001;276:18169-18177.
43. 2+-induced regulation of ion channel and MAP kinase functions. Nature 1995;376:737-745.
44. Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J: A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 1996;383:547-550.
45. Soltoff SP: Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P-2Y2 receptor. J Biol Chem 1998;273:23110- 23117.
46. Satoh K, Ichihara K, Landon EJ, Inagami T, Tang H: 3-Hydroxy-3- methylglutaryl-CoA reductase inhibitors block calcium-dependent tyrosine kinase Pyk2 activation by angiotensin II in vascular endothelial cells - Involvement of geranylgeranylation of small G protein Rap1. J Biol Chem 2001;276:15761- 15767.
47. Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ: Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of G(i)- and G(q)-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem 1997;272:19125-19132.
48. Andreev J, Galisteo ML, Kranenburg O, Logan SK, Chiu ES, Okigaki M, Cary LA, Moolenaar WH, Schlessinger J: Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. J Biol Chem 2001;276:20130-20135.
49. van Corven EJ, Hordijk PL, Medema RH, Bos JL, Moolenaar WH: Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts. Proc Natl Acad Sci USA 1993;90:1257-1261.
50. Della Rocca GJ, Maudsley S, Daaka Y, Lefkowitz RJ, Luttrell LM: Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases. J Biol Chem 1999;274:13978-13984.
51. Luttrell LM, Daaka Y, Della Rocca GJ, Lefkowitz RJ: G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in Rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of ERK kinases. J Biol Chem 1997;272:31648-31656.
52. Luttrell LM, Ferguson SSG, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin FT, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ: Beta-arrestin-dependent formation of beta(2) adrenergic receptor Src protein kinase complexes. Science 1999;283:655-661.
53. Cao WH, Lutrell LM, Medvedev AV, Pierce KL, Daniel KW, Dixon TM, Lefkowitz RJ, Collins S: Direct binding of activated c-Src to the beta(3)-adrenergic receptor is required for MAP kinase activation. J Biol Chem 2000;275: 38131-38134.
54. Pierce KL, Tohgo A, Ahn S, Field ME, Luttrell LM, Lefkowitz RJ: Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors. A co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J Biol Chem 2001;276:23155-23160.
55. Pierce KL, Luttrell LM, Lefkowitz RJ: New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 2001;20:1532-1539.
56. DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, Dery O, Bunnett NW: The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA 2000;97:11086-11091.
57. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, Bunnett NW: Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 2000;148:1267-1281.
58. Stephens L, Eguinoa A, Corey S, Jackson T, Hawkins PT: Receptor stimulated accumulation of phosphatidylinositol (3,4,5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells. EMBO J 1993;12:2265-2273.
59. Kumagai N, Morii N, Fujisawa K, Nemoto Y, Narumiya S: ADP-ribosylation of Rho p21 inhibits lysophosphatidic acid-induced protein tyrosine phosphorylation and phosphatidylinositol 3-kinase activation in cultured Swiss 3T3 cells. J Biol Chem 1993;268:24535-24538.
60. Hawes BE, Luttrell LM, van Biesen T, Lefkowitz RJ: Phosphatidylinositol 3-kinase is an early intermediate in the G-beta-gamma-mediated mitogen-activated protein kinase signaling pathway. J Biol Chem 1996;271:12133-12136.
61. Lopezi-Ilasaca M, Crespo P, Pellici PG, Gutkind JS, Wetzker R: Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI3-kinase gamma. Science 1997;275:394-397.
62. Pombo CM, Zalvide J, Gaylinn BD, Dieguez C: Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. Endocrinology 2000;141:2113-2119.
63. Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A: Signal characteristics of G protein-transactivated EGF receptor. EMBO J 1997;16:7032-7044.
64. Kranenburg O, Moolenaar WH: Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists. Oncogene 2001;20:1540-1546.
65. Duckworth BC, Cantley LC: Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. Dependence of signal strength. J Biol Chem 1997;272:27665-27670.
66. Prasad SVN, Barak LS, Rapacciuolo A, Caron MG, Rockman HA: Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration. J Biol Chem 2001;276:18953-18959.
67. Simonsen A, Lippe R, Christoforidis S, Gaullier JM, Brech A, Callaghan J, Toh BH, Murphy C, Zerial M, Stenmark H: EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature 1998;394:494-498.
68. Enslen H, Tokumitsu H, Stork PJS, Davis RJ, Soderling TR: Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade. Proc Natl Acad Sci USA 1996;93:10803-10808.
69. 2+/ calmodulin translocation activated by mu-opioid (OP3) receptor. J Neurochem 2000;74:1418-1425.
70. 2+- dependent binding of calmodulin to an N-terminal motif of the heterotrimeric G protein beta subunit. J Biol Chem 1997;272:18801-18807.
71. 2+/calmodulin. J Biol Chem 1996;271:28691-28696.
72. Joyal JL, Burks DJ, Pons S, Matter WF, Vlahos CJ, White WF, Sacks DB: Calmodulin activates phosphatidylinositol 3-kinase. J Biol Chem 1997;272:28183-28186.
73. Liang L, Leong K, Seow KT, Ng CH, Pallen CJ: Calmodulin binds to and inhibits the activity of the membrane distal catalytic domain of receptor protein-tyrosine phosphatase alpha. J Biol Chem 2000;275:30075-30081.
74. Zwick E, Wallasch C, Daub H, Ullrich A: Distinct calcium-dependent pathways of epidermal growth factor receptor transactivation and Pyk2 tyrosine phosphorylation in PC12 cells. J Biol Chem 1999;274:20989-20996.
75. Della Rocca GJ, Mukhin YV, Garnovskaya MN, Daaka Y, Clark GJ, Luttrell LM, Lefkowitz RJ, Raymond JR: Serotonin 5-HT1A receptor-mediated ERK activation requires calcium/calmodulin-dependent receptor endocytosis. J Biol Chem 1999;274:4749-4753.
76. 2+/calmodulin-sensitive tyrosine kinase. J Biol Chem 1996;271: 14169-14175.
77. Egea J, Espinet C, Comella JX: Calcium influx activates extracellular-regulated kinase/mitogen-activated protein kinase pathway through a calmodulin-sensitive mechanism in PC12 cells. J Biol Chem 1999;274:75-85.
78. Farnsworth CL, Freshney NW, Rosen LB, Ghosh A, Greenberg ME, Feig LA: Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF. Nature 1995;376:524-527.
79. Ebinu JO, Bottorff DA, Chan EYW, Stang SL, Dunn RJ, Stone JC: RasGRP, a Ras guanyl nucleotide-releasing protein with calcium- and diacylglycerol- binding motifs. Science 1998;280:1082-1086.
80. 2+ and calmodulin. Mol Cell Biol 2000;20:1931-1946.
81. Minakami R, Jinnai N, Sugiyama H: Phosphorylation and calmodulin binding of the metabotropic glutamate receptor subtype 5 (mGlur5) are antagonistic in vitro. J Biol Chem 1997;272:20291-20298.
82. Wang DX, Sadee W, Quillan JM: Calmodulin binding to G protein-coupling domain of opioid receptors. J Biol Chem 1999;274:22081-22088.
83. Heuss C, Gerber U: G-protein-independent signaling by G-protein-coupled receptors. Trends Neurosci 2000;23:469-475.
84. Bofill-Cardona E, Kudlacek O, Yang Q, Ahorn H, Freissmuth M, Nanoff C: Binding of calmodulin to the D-2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch. J Biol Chem 2000;275:32672-32680.
85. Belcheva MM, Szucs M, Wang D, Sadee W, Coscia CJ: Mu-opioid receptor-mediated ERK-activation involves calmodulin-dependent EGF receptor transactivation. J Biol Chem 2001;276:33847-33853.
86. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, Rapp UR: Protein kinase-C-alpha activates Raf-1 by direct phosphorylation. Nature 1993;364:249-252.
87. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S: Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 1996;271:23512-23519.
88. Marais R, Light Y, Mason C, Paterson H, Olson MF, Marshall CJ: Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 1998;280:109-112.
89. Daub H, Weiss FU, Wallasch C, Ullrich A: Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996;379:557-560.
90. 2+, PYK-2, and p60 (Src). J Biol Chem 2000;275:12691-12625.
91. Maudsley S, Pierce KL, Zamah AM, Miller WE, Ahn S, Daaka Y, Lefkowitz RJ, Luttrell LM: The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem 2000;275:9572-9580.
92. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A: EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999;402: 884-888.
93. Carpenter G: EGF receptor transactivation mediated by the proteolytic production of EGF-like agonists. STKE 2000;15:1-3 (Science's STKE:http://stke.sciencemag.org/cgi/content/full/OC_sigtrans; 2001/15/pe1).
94. Roudabush FL, Pierce KL, Maudsley S, Khan KD, Luttrell LM: Transactivation of the EGF receptor mediates IGF-1-stimulated Shc phosphorylation and ERK1/2 activation in COS-7 cells. J Biol Chem 2000;275:22583-22589.
95. Dong JY, Wiley HS: Trafficking and proteolytic release of epidermal growth factor receptor ligands are modulated by their membrane-anchoring domains. J Biol Chem 2000;275:557-564.
96. Diaz-Rodriguez F, Esparis-Ogando A, Montero JC, Yuste L, Pandiella A: Stimulation of cleavage of membrane proteins by calmodulin inhibitors. Biochem J 2000;346:359-367.
97. Bosch M, Gil J, Bachs O, Agell N: Calmodulin inhibitor W13 induces sustained activation of ERK2 and expression of p21(Cip1). J Biol Chem 1998;273:22145-22150.
98. Linseman DA, Benjamin CW, Jones DA: Convergence of angiotensin ii and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem 1995;270:12563-12568.
99. Herrlich A, Daub H, Knebel A, Herrlich P, Ullrich A, Schultz G, Gudermann T: Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. Proc Natl Acad Sci USA 1998;95:8985-8990.
100. Tan Y, Belcheva MM, Haas P, Coscia CJ: Delineation of the mechanism of ERK regulation by mu-opioids in an astrocytic model system. Soc Neurosci Abstr 2001;27:39.
101. Rao GN, Delafontaine P, Runge MS: Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phospholipase C-gamma-1 in rat aortic smooth muscle cells. J Biol Chem 1995;270:27871-27875.
102. Roth BL, Willins DL, Kroeze WK: G protein-coupled receptor (GPCR) trafficking in the central nervous system. Relevance for drugs of abuse. Drug Alcohol Depend 1998;51:73-85.
103. Vieira AV, Lamaze C, Schmid SL: Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 1996;274:2086-2089.
104. Luttrell LM, Della Rocca GJ, van Biesen T, Luttrell DK, Lefkowitz RJ: G-beta-gamma subunits src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J Biol Chem 1997;272:4637-4644.
105. Daaka Y, Luttrell LM, Ahn S, Della Rocca GJ, Ferguson SSG, Caron MG, Lefkowitz RJ: Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J Biol Chem 1998;273:685-688.
106. Ignatova EG, Belcheva MM, Bohn LM, Neuman MC, Coscia CJ: Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: Biochemical and immunofluorescence confocal microscopic evidence. J Neurosci 1999;19:56-63.
107. Ahn S, Maudsley S, Luttrell LM, Lefkowitz RJ, Daaka Y: Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling. J Biol Chem 1999;274:1185-1188.
108. Vogler O, Nolte B, Voss M, Schmidt M, Jakobs KH, van Koppen CJ: Regulation of muscarinic acetylcholine receptor sequestration and function by beta-arrestin. J Biol Chem 1999;274:12333-12338.
109. Kramer HK, Andria ML, Esposito DH, Simon EJ: Tyrosine phosphorylation of the delta-opioid receptor. Evidence for its role in mitogen-activated protein kinase activation and receptor internalization. Biochem Pharmacol 2000;60:781-792.
110. Pierce KL, Maudsley S, Daaka Y, Luttrell LM, Lefkowitz RJ: Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonse-questering G protein-coupled receptors. Proc Natl Acad Sci USA 2000;97:1489-1494.
111. Ferguson SSG: Evolving concepts in G protein-coupled receptor endocytosis: The role in receptor desensitization and signaling. Pharmacol Rev 2001;53:1-24.
112. Whistler JL, von Zastrow M: Dissociation of functional roles of dynamin in receptor-mediated endocytosis and mitogenic signal transduction. J Biol Chem 1999;274:24575-24578.
113. Schramm NL, Limbird LE: Stimulation of mitogen-activated protein kinase by G protein-coupled alpha(2)-adrenergic receptors does not require agonist-elicited endocytosis. J Biol Chem 1999;274:24935-24940.
114. Li JG, Luo LY, Krupnick JG, Benovic JL, Liu-Chen LY: U50, 488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. J Biol Chem 1999;274:12087-12094.
115. DeGraff JL, Gagnon AW, Benovic JL, Orsini MJ: Role of arrestins in endocytosis and signaling of alpha(2)-adrenergic receptor subtypes. J Biol Chem 1999;274:11253-11259.
116. Pawson T, Scott JD: Signaling through scaffold, anchoring, and adaptor proteins. Science 1997;278:2075-2080.
117. Whitmarsh AJ, Davis RJ: Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem Sci 1998;23:481-485.
118. Burack WR, Shaw AS: Signal transduction: Hanging on a scaffold. Curr Opin Cell Biol 2000;12:211-216.
119. Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A, Weber MJ: MP1: A MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 1998;281:1668-1671.
120. Xing HR, Lozano J, Kolesnick R: Epidermal growth factor treatment enhances the kinase activity of kinase suppressor of Ras. J Biol Chem 2000;275:17276-17280.
121. Morrison DK: KSR: A MAPK scaffold of the Ras pathway? J Cell Sci 2001;114:1609-1612.
122. Wunderlich W, Fialka I, Teis D, Alpi A, Pfeifer A, Parton RG, Lottspeich F, Huber LA: A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold MP1 on a late endosomal/lysosomal compartment. J Cell Biol 2001;152:765-776.
123. Schlaepfer DD, Hunter T: Signal transduction from the extracellular matrix - A role for the focal adhesion protein-tyrosine kinase FAK. Cell Struct Funct 1996;21:445-450.
124. McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, Lefkowitz RJ: Beta-arrestin 2: A receptor-regulated MAPK scaffold for the activation of JNK3. Science 2000;290:1574-1577.
125. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, Lefkowitz RJ: Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci USA 2001;98: 2449-2454.
126. Miller WE, Lefkowitz RJ: Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Curr Opin Cell Biol 2001;13:139-145.